Market & Industry Briefs
Executive Summary
Brief summaries of recent medtech market and industry developments. This month we cover a new GAO report that ups the pressure on the medical imaging market; Cordis Corp.'s suspension of its PFO closure device program; Atritech's PMA for stroke prevention; Zimmer's acquisition of Abbott Spine; and the US market for contraception devices and procedures.
You may also be interested in...
Health Care Trends: Cost Control Measures in Full Swing
Affordability drives medical devices purchases and use. Even the most remarkable devices can see a tremendous downturn in usage is reimbursement is lowered. That's why an an annoucement that CMS is considering changes to coverage of certain medical procedures is making device company CEOs more than a little nervous.
Health Care Trends: Cost Control Measures in Full Swing
Affordability drives medical devices purchases and use. Even the most remarkable devices can see a tremendous downturn in usage is reimbursement is lowered. That's why an an annoucement that CMS is considering changes to coverage of certain medical procedures is making device company CEOs more than a little nervous.
PFO Closure: Challenges and Opportunities
Over the past several years, device manufacturers have introduced a number of PFO closure devices in Europe, but conducting randomized trials to gain US market approval has proven to be a much more difficult endeavor. Companies have experienced numerous delays and setbacks in both their stroke and migraine programs. The good news: setbacks for some could also boost randomized migraine studies still ongoing by other competitors in this field.